• In the News

  With Firdapse LEMS Launch, Catalyst Estimates 2019 Revenues of $102M

  Posted by Forum Moderator on March 25, 2020 at 9:53 am

  

  Catalyst expects to report 2019 net product revenues of $102 million for Firdapse, the first and only therapy for the symptomatic treatment of LEMS. Read more about it here.

  What did you think of this article?

  Forum Moderator replied 4 years, 1 month ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply